This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Today, cannabis-based therapies provide relief to over 6 million Americans registered in medical cannabis programs in 38 states, D.C., territories, often serving as a crucial alternative when conventional treatments have failed or as a safer option compared to pharmaceuticals. and four of the five U.S.
The Decline of Medical Marijuana in Massachusetts: What It Means for Patients In recent years, Massachusetts, once a pioneer in cannabis reform, has seen its medical marijuana program gradually overshadowed by the booming recreational market. The program aimed to provide safe, legal access to cannabis for patients with chronic conditions.
The Grant Program Details The heart of this landmark legislation lies in the development of a robust grant program. Notably, the grant program will target three prevalent and often debilitating conditions in military personnel: PTSD, traumatic brain injury (TBI) , and chronic traumatic encephalopathy (CTE).
In addition to the pilot program, the parties are working toward an exclusive, definitive supply and distribution agreement, which, if entered into, is expected to position Medicann as the sole supplier and distributor of the RYAH Smart Dry Herb Inhalers in the region. In 2019, the island’s economy grew by 2.1% in real terms to £4.97
In January, a bill was introduced regarding Iowas medical cannabis program, allowing vaporized cannabis to be added to the state-approved Tetrahydrocannabinol ( THC) products list. Iowas medical cannabis program is one of the most limited throughout the country. This bill was advanced out of a House subcommittee.
Florida-based cannabis giant Trulieve recently doubled its contribution to the Smart & Safe Florida political committee with another $5 million toward a 2024 ballot initiative to legalize adult-use cannabis. 1, 2024, with election officials needing 30 days to check signatures before that deadline. 23 to circulate the petition.
Quemarr Moatamedi School: University of Montana Major/Program: Linguistics and Anthropology Innovation: Emulsion-Based Edibles: Harnessing Anti-Diabetic Cannabinoids in Diabetes Management. Quemarr’s transformative approach to diabetes treatment offers patients a less intrusive alternative to conventional insulin treatments.
The company’s target is 20 clinics by the end of 2024. “The NEO listing will enable us to accelerate the execution of our drug discovery, therapy development, advanced analytics, and open clinic rollout programs.”. . by Toronto-based Awakn Life Sciences Inc. David Nutt), starts in Q4 2021.
If ratified as it is expected to be, the new CBA will take effect in the 2023-2024 season and remain in place until at least 2029. With a second violation, players face a $25,000 fine and in-patient or aftercare treatment in the Marijuana Program.
A 2022 study , for example, found that psilocybin can help patients struggling with treatment-resistant depression. experts predict that MDMA could gain FDA approval and be available in hospitals as soon as 2024. Since then, the program has only gotten bigger, amassing $900 million in sales between 2020 and 2021. In the U.S.,
Alabama legalized medical a medical cannabis program on May 17, 2021 when Governor Ivey signed SB 46 into law. Although medical cannabis program was signed into law last year, it has yet to be fully implemented. Since then, the legislature has passed a number of laws that have expanded the state’s medical cannabis program.
Suzanne Mulvehill is a Clinical Sexologist, Orgasmologist, and the Executive Director of the Female Orgasm Research Institute , which is dedicated to conducting research and identifying scientifically based treatments to reduce the persistently high percentage of women suffering from orgasm difficulty and its co-morbid conditions. Marialle A.
The moneys shall be used to fund crime prevention programs, training, and interdiction efforts, including detection, enforcement, and prevention efforts, relating to the illegal cannabis market and driving under the influence of cannabis. (C)
This Commission would be tasked with licensing oversight, patient cannabis supply issues, and program-allocated revenue generation. Additionally, North Carolina’s amended medical cannabis bill calls for a nine-member Medical Cannabis Production Commission to be created.
million in 2024 and $38.4 The board will support locally designed and community-based responses that include grants for workforce development, apprenticeship, and reentry programs, and scholarships for historically marginalized individuals. “We Shane Emmett of Midlothian, Co-Founder and Former Chief Executive Officer, Health Warrior.
Despite the tax cut, a recent analysis found that removing the cultivation tax would actually increase overall tax revenue from cannabis sales by 123 percent by 2024 due to an expected increase in sales. million from the Governor’s Budget estimate.
The Autism CARES Act ensures support for research on autism spectrum disorder ( ASD ) and enhances programs relating to autism. The latest version of the Act renews the legislation for another five years, tagging $369M annually for ASD-efforts through 2024. The appropriation of funds authorizes agencies to spend $23.1M
We note that New York’s cannabis licensing program is facing yet another lawsuit. The letter raises concerns about the potential for abuse, a lack of medical treatment potential, and trafficking by criminal gangs. It seems likely that 2024 will bring a decision on re-scheduling, either for or against, so stay tuned for that.
Setting Allocation 3 funding for youth education/intervention/ treatment, environmental restoration, and state and local law enforcement programs at a baseline of $670 million annually for three years. The grant program will assist cities and counties that do not currently license storefront or delivery-only cannabis retailers.
Recommendations and rulemaking relating to training and products were placed on an expedited timeline to ensure that facilitators will be trained, and products will be ready for the January 2, 2023, launch of the first state-sponsored psilocybin therapy program in the United States. Conducting Psilocybin Integration (14 Hours).
Khiron in the United Kingdom The company is pursuing a consistent approach to improve patient access to medical cannabis and to develop the market for medical cannabis treatments in the UK.
According to the Associated Press, Virginia lawmakers gave final approval Saturday to a bill that will legalize marijuana for adult recreational use, but not until 2024, when retail sales of the drug would also begin. The bill calls for dedicating 30% of marijuana tax revenue — after program costs — to a Cannabis Equity Reinvestment Fund.
Gold Leaf is one of only 22 licensed centers and one of only 16 active operators in Florida, and the organization is planning to open 20 dispensaries in the state by 2024. Cumulatively, all of the 10-year agreements under Agrify’s TTK Solution program are currently projected to generate an estimated $850 million in total revenue.
Retail sales will not begin until January 1, 2024. Regardless, all employers with drug and alcohol testing programs should consider a fresh review of their policies to decide whether they will continue to test for marijuana and, if so, the circumstances under which tests will occur and the consequences for failed drug tests.
The Oregon Psilocybin Advisory Board (Advisory Board) held a meeting on October 27 to begin fine tuning recommendations for the first regulated psilocybin treatment model in the United States. These recommendations require OAH to review allowable species every 12 months starting in January 2024. By Brett Mulligan.
economy by 2024. Players are constantly looking for treatment options that can improve their quality of life but they are also concerned about the impact these treatments can have on their performance.If Finding the right product for any pain management program can be overwhelming.
Previously, the Colorado Springs council recently cast a second vote regarding the recreational marijuana ordinance in September of 2024. While California was the first state to legalize medical cannabis in 1996, just a few years later, the state established a Colorado medical marijuana program through a ballot measure in 2000.
The retail provisions are set to take effect on January 1, 2024, but this deadline could be expedited by lawmakers. Senate Bill 46 : The legislation establishes a medical cannabis access program that permits registered patients to possess up to “70 daily dosages” of medical marijuana at one time, with each dose at a maximum of 50 milligrams.
In short, cannabis went from an alternative treatment to an essential medicine, giving it a major upgrade in credibility. billion in annual medical and recreational cannabis sales by 2024. Separately, lawmakers in Vermont approved a recreational marijuana program last October. 1, 2024, start. 1, 2024, start.
The bill also establishes a tax structure and directs revenue to various initiatives, including Pre-K programs, disadvantaged communities, substance abuse treatment and public health. Eliminate special treatment of registered hemp processors (the current version of the bill creates a loophole with respect to license caps.).
Under New Jersey’s adult-use cannabis law, medical cannabis dispensaries that are currently operating across the state—where hundreds of thousands of people have enrolled to receive cannabis-based treatments—are readily licensed to carry out adult-use commerce. 31, 2022 and the conditional program will come to an end on June 30, 2024.
The Hall Act establishes the Alabama Medical Cannabis Commission, which will, among other things, implement a medical marijuana program in the state and provide an annual report to the state legislature about the implementation of the law. The retail sale of marijuana in Virginia, however, will not begin until January 1, 2024.
New Mexico expands medical cannabis program to include protections against discrimination, reciprocity with other states’ medical programs, and three-year renewal cycle (up from one) for medial cannabis cards; and. Nebraska farmers looking to grow hemp this season have until 5 p.m. The panel also took up a bill sponsored by Rep.
Since 2014 when sales began in Colorado and Washington, legalization policies have provided states a new revenue stream to bolster budgets and fund important services and programs. Colorado has a robust medical program, with about 1.6% Legalizing cannabis for adults has been a wise investment. of the population enrolled.
Oregon statute currently forbids the sale of adult-use cannabis items to minors,[4] and the task force is pushing to give the OLCC authority to create a minor decoy program to test whether retailers are complying with the statute. 1, 2024, which would allow for similar enforcement operations in the future.
Retail sales will not begin until January 1, 2024. Regardless, all employers with drug and alcohol testing programs should consider a fresh review of their policies to decide whether they will continue to test for marijuana and, if so, the circumstances under which tests will occur and the consequences for failed drug tests.
from the second half of 2021 onwards as the Group fully repaid in May and June 2021 its 2022 and 2023 Eurobonds and successfully purchased a significant portion of its 2024 and 2026 Eurobonds which were bearing much higher interest rates. Second investment grade credit rating from Fitch Ratings after the one secured with Moody’s last year.
In 2024, we may finally see adult use marijuana in Florida. Further, Medical Marijuana Treatment Centers (MMTCs) (the only entities that can make and sell cannabis products) would also be the ones to make and dispense adult use products (unless the state decides to license other entities, too). We will keep you posted.
While costs to access ketamine therapy can be high in some locations, and like any drug ketamine is not a cure-all, some patients and their doctors have been reporting life-changing results when no other treatment provided relief. Patients may want to seek assistance from a certified professional prior to embarking on treatment.
It’s not a big drop, but this was the first year I saw license numbers fall since the 2016 roll-out of the adult use program. Yes, the HB 4016 licensing moratorium sunsets on March 31, 2024, but I’m guessing our legislators will pass an extension bill early in the 2024 session. Now, it’s all CIAO. Good luck Andrew!
Our readers and followers reacted the most to the one positive story about the Illinois Department of Public Health (IDPH) adding four new conditions to the list of qualifying debilitating condition for medical patients in the Compassionate Use of Medical Cannabis Program. 7, 2023, but did not meet again until March 11, 2024.
Cannabis tax dollars could help fund programs in those areas. He also said making cannabis legal frees police to focus on more violent criminals and provides another treatment option for those with chronic and terminal illnesses. million people to make cannabis legal for adult use, and that won’t start until 2024.
Now, the state has officially launched its medical cannabis program, making it the 38th state to legalize medical marijuana. This long-anticipated development marks a major shift in Kentuckys stance on cannabis, opening new doors for patients seeking alternative treatments.
HB 1453 seeks to alleviate the unfair tax burden on medical cannabis patients and providers On March 6, 2024, the Washington Senate passed HB 1453 which will provide an exemption from the 37% excise tax for medical cannabis patients and designated providers. The bill now waits for signatures and executive action to become law.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content